[HTML][HTML] Immunology of COVID-19: current state of the science
The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has affected millions of people worldwide, igniting …
syndrome coronavirus 2 (SARS-CoV-2) has affected millions of people worldwide, igniting …
T cell activation, highly armed cytotoxic cells and a shift in monocytes CD300 receptors expression is characteristic of patients with severe COVID-19
O Zenarruzabeitia, G Astarloa-Pando, I Terren… - Frontiers in …, 2021 - frontiersin.org
COVID-19 manifests with a wide diversity of clinical phenotypes characterized by
dysfunctional and exaggerated host immune responses. Many results have been described …
dysfunctional and exaggerated host immune responses. Many results have been described …
[HTML][HTML] Expansion of SARS-CoV-2–specific antibody-secreting cells and generation of neutralizing antibodies in hospitalized COVID-19 patients
R Varnaitė, M García, H Glans, KT Maleki… - The Journal of …, 2020 - journals.aai.org
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), emerged in late 2019 and has since become a …
syndrome coronavirus 2 (SARS-CoV-2), emerged in late 2019 and has since become a …
Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent
BACKGROUND Coronavirus disease 19 (COVID-19) is an emerging infectious disease
caused by SARS-CoV-2. Antiviral immune response is crucial to achieve pathogen …
caused by SARS-CoV-2. Antiviral immune response is crucial to achieve pathogen …
[HTML][HTML] SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay
I Cassaniti, E Percivalle, F Bergami, A Piralla… - Clinical Microbiology …, 2021 - Elsevier
Abstract Objectives SARS-CoV-2 T-cell response characterization represents a crucial issue
for defining the role of immune protection against COVID-19. The aim of the study was to …
for defining the role of immune protection against COVID-19. The aim of the study was to …
Monocytes and macrophages, targets of severe acute respiratory syndrome coronavirus 2: the clue for coronavirus disease 2019 immunoparalysis
Abstract Background Coronavirus disease 2019 (COVID-19) clinical expression is
pleiomorphic, severity is related to age and comorbidities such as diabetes and …
pleiomorphic, severity is related to age and comorbidities such as diabetes and …
Characterization of SARS-CoV-2-specific humoral immunity and its potential applications and therapeutic prospects
J Zheng, Y Deng, Z Zhao, B Mao, M Lu, Y Lin… - Cellular & molecular …, 2022 - nature.com
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is an ongoing pandemic that poses a great threat to …
syndrome coronavirus 2 (SARS-CoV-2), is an ongoing pandemic that poses a great threat to …
[HTML][HTML] Cell-type-specific immune dysregulation in severely ill COVID-19 patients
Recent studies have demonstrated immunologic dysfunction in severely ill coronavirus
disease 2019 (COVID-19) patients. We use single-cell RNA sequencing (scRNA-seq) to …
disease 2019 (COVID-19) patients. We use single-cell RNA sequencing (scRNA-seq) to …
Profound dysregulation of T cell homeostasis and function in patients with severe COVID‐19
Abstract Background Coronavirus disease 2019 (COVID‐19) is caused by infection with
severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) and shows a broad clinical …
severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) and shows a broad clinical …
[HTML][HTML] COVID-19: Unanswered questions on immune response and pathogenesis
The novel coronavirus disease 2019 has rapidly increased in pandemic scale since it first
appeared in Wuhan, China, in December 2019. In these troubled days the scientific …
appeared in Wuhan, China, in December 2019. In these troubled days the scientific …